Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Directed gene modification via triple helix formation.

L Gorman1, P M Glazer

  • 1Department of Therapeutic Radiology, Yale University School of Medicine, Boyer Center for Molecular Medicine, New Haven, CT 06536, USA.

Current Molecular Medicine
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relaxation dynamics in excited helium nanodroplets probed with high resolution, time-resolved photoelectron spectroscopy.

Physical chemistry chemical physics : PCCP·2022
Same author

Serum Beta Hydroxybutyrate Concentrations in Cats with Chronic Kidney Disease, Hyperthyroidism, or Hepatic Lipidosis.

Journal of veterinary internal medicine·2016
Same author

Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Gene therapy·2012
Same author

Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.

Oncogene·2006
Same author

Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination.

Nucleic acids research·2002
Same author

Genomic instability in cancer.

Novartis Foundation symposium·2001
Same journal

Corrigendum to: Sortilin as a Culprit in the Atherosclerosis Plaque Progression: Evidence from Clinical and Experimental Studies.

Current molecular medicine·2026
Same journal

Dynamic Expression of Fibroblast Activation Protein (FAP) During Chronic Pancreatitis (CP) Progression in Mice and Evaluation of FAP-targeted Tracers for Early CP Diagnosis.

Current molecular medicine·2026
Same journal

Causal Relationship Between 91 Inflammatory Factors and Gastritis: A Two-Sample Bidirectional Mendelian Randomization Study.

Current molecular medicine·2026
Same journal

Therapeutic Potential of Pistacia Atlantica Gum in Aspirin-Induced Peptic Ulcers: A Dose-Dependent Approach to Mucosal Protection and Hepatorenal Safety.

Current molecular medicine·2026
Same journal

Identification and Characterization of MicroRNAs Associated with Borax-mediated Anti-tumor Activity through High-throughput Technology.

Current molecular medicine·2026
Same journal

Broad-Spectrum Vaccines: Challenges and Opportunities (A Systematic Review).

Current molecular medicine·2026
See all related articles

Gene therapy advances with new methods to target and modify DNA. Molecules like triplex forming oligonucleotides (TFOs) and peptide nucleic acids (PNAs) enable precise gene correction for genetic diseases.

Area of Science:

  • Molecular Biology
  • Genetics
  • Gene Therapy

Background:

  • Genetic diseases often stem from single nucleotide mutations causing non-functional gene products.
  • Restoring correct gene sequences offers potential permanent cures for inherited disorders.

Purpose of the Study:

  • To explore advanced gene targeting methods for therapeutic applications.
  • To investigate the role of specific molecules in gene modification.

Main Methods:

  • Utilizing triplex forming oligonucleotides (TFOs) for DNA binding.
  • Employing peptide nucleic acids (PNAs) for genomic targeting.

Main Results:

  • TFOs and PNAs demonstrate capability to bind double-stranded DNA.

Related Experiment Videos

  • These molecules represent a foundational step for efficient genomic DNA targeting.

    • Conclusions:

    • Selective gene targeting is crucial for gene therapy advancements.
    • TFOs and PNAs are promising tools for precise gene modification and potential disease treatment.